Wednesday, April 16, 2014

Emerging Growth Stocks: Examining best rebounding charts in mj sector....CANN ERBB CBIS on news

 
 
Sent: Wednesday, April 16, 2014 10:55 AM
Subject: Emerging Growth Stocks: Examining best rebounding charts in mj sector....CANN ERBB CBIS on news
 
 
Enclosed is a recent newsletter sampling from www.greenbackers.com
 
Hope you can utilize from time to time.
 
Staff @ Greenbackers
 
 
 
 
Sent: Wednesday, April 16, 2014 9:14 AM
To: Undisclosed-Recipient:;
Subject: Examining best rebounding charts in mj sector....CANN
 
Focus:
 
Plenty of rebound plays taking shape in mj sector....
 
 
Recall rebound related discussions on CANN after debacle from .30 following trading resumption...Continues to do so...straight upping since the getgo....Recall in industrial farming...
Last Change / % Change Dividend Yield Volume Avg Volume (10 day) S&P Capital IQ Ranking
16.35  3.10   23.40% 0.00% 26,275 44.5K
 
 
 
 
 
 
Prior 'most beaten down in April (from .45) mention SPLI advancing from .05 low yesterday...We said to debate for jumping back above .10...ran to .109....Focusing on the dip back under...
Last Change / % Change Dividend Yield Volume Avg Volume (10 day) S&P Capital IQ Ranking
0.097  0.011   12.79% 0.00% 28,735,308 31.2M
 
 
 
CBIS a nice jump back above .10 also on news...Hearing Dr. Melamede has numerous connections in the industry, especially in Europe...
 
Last Change / % Change Dividend Yield Volume Avg Volume (10 day) S&P Capital IQ Ranking
0.1009  0.0129   14.66% 0.00% 5,215,150 17.6M

Mountain High Appoints Leading Cannabis Authority Dr. Robert Melamede Ph.D. as Scientific Advisor

Mountain High Appoints Leading Cannabis Authority Dr. Robert Melamede Ph.D. as Scientific Advisor DENVER, CO--(Marketwired - Apr 16, 2014) - Mountain High Acquisitions Corp. (OTCQB: MYHI) ("Mountain High" or the "Company"), is pleased to announce that leading cannabis authority Dr. Robert Melamede, Ph.D. has joined the Advisory Board of the Company.

"Dr. Melamede is a visionary and a pioneer in the field of medicinal cannabis research, so we are greatly honored that he has agreed to join our team as Scientific Advisor," stated Mr. Alan Smith, President of Mountain High Acquisitions Corp. "His years of leading scientific research and cannabis advocacy have earned him a reputation as a vital industry source of knowledge, opinion, industry contacts, and inspiration. As our new Scientific Advisor, we are confident that he will be instrumental in helping us achieve our corporate objectives. In particular, his advice will be invaluable as we provide additional complementary services to current and future cannabis growing tenants and strategically develop our properties for use by the cannabis industry."

Dr. Robert Melamede is recognized as a leading authority on the therapeutic uses of cannabis, and has authored or co-authored dozens of papers on a wide variety of scientific subjects. Dr. Melamede is the President of Cannabis Science, Inc. (OTCQB: CBIS), a medical cannabis research and development company, and an advisor to Enertopia Corporation (OTCQB: ENRT), a company with a medical marijuana cultivation joint venture. Dr. Melamede also serves on the Editorial Board of The Journal of the International Association for Cannabis as Medicine, the Scientific Advisory Board of Americans for Safe Access, Sensible Colorado, Scientific Advisor for Cannabis Therapeutics, as well as a variety other of state dispensaries and marijuana patient advocacy groups. Dr. Melamede has a Ph.D. in Molecular Biology and Biochemistry from the City University of New York. Dr. Melamede retired as Chairman of the Biology Department at University of Colorado, Colorado Springs, in 2005, where he continues to teach and research cannabinoids, cancer, and DNA repair.

 
 
 
 
Examining ERBB activity on the news we mentioned our prior newsletter......Hearing there was plenty of press coverage on the ZaZZZ in Calif on local news stations around LA region...
Last Change / % Change Dividend Yield Volume Avg Volume (10 day) S&P Capital IQ Ranking
0.0507  0.0057   12.67% 0.00% 58,944,776 141.2M

Doctors Orders

Last Change / % Change Dividend Yield Volume Avg Volume (10 day) S&P Capital IQ Ranking
0.0507  0.0057   12.67% 0.00% 58,944,776 141.2M

-- One of Colorado's Best Known Marijuana Dispensary Groups Orders the ZaZZZ American Green(TM) Machines for Its Dispensaries

 

According to Stephen Shearin, Tranzbyte's chief operating officer, "We are readying the first of several American Green ZaZZZ automated machines resulting from last week's unveiling in Avon, CO on April 12, and it will be placed at the Doctors Orders Denver dispensary. We are very happy to be working with one of Colorado's premier medical and adult-use marijuana dispensary groups." According to Josh Bartch, Doctors Orders' president, "I believe that the ZaZZZ American Green Machine will fit perfectly in our environment and can be easily and securely operated by our customers. I'm very excited that we will be the first dispensary in Denver to use what we believe will be a revolutionary machine."

David Gwyther, Tranzbyte's president states, "We are thrilled that our ZaZZZ unveiling event last week in Avon, Colorado has been so well received by the national media. Tranzbyte and American Green feel that the national debate has shifted from 'Is marijuana dangerous?' to 'How can it be procured safely?' We are very proud to be a contributor to that dialogue."

Tranzbyte encourages all folks wishing to follow the progress of Tranzbyte, American Green™, and its other subsidiaries and divisions to visit the Tranzbyte website at www.tranzbyte.com and sign up to receive our 'Email Alerts' which are sparingly sent to interest-holders periodically. Just click on the orange 'contact' button after arriving at the company's website. Mobile users can also sign up by navigating to the company's website on their android smart phone or iPhone. Also, shareholder and other interest-holders may track the progress of our fully automated ZaZZZ™ Machine by following us on Twitter @Tranzbyte or @American__Green (two underscores).

 

 

 

 
 
 
 
Greenbackers specializes in providing trading ideas via newsletters, on rapidly growing companies for short and long term investors.
 
We offer monthly subscriptions for our daily pre-market and midday newsletters for the reduced rate of  $19.95 per month.
 
Try us out by clicking below
 
 
 
             
 
 
 
                      www.greenbackers.com

 

 

To unsubscribe, reply to email with 'unsubscribe' in subject line.

 

Disclosure:  Greenbackers is long ERBB                                                                    

 
Greenbackers will use reasonable efforts to include accurate and up-to-date information on this website but makes no representations, warranties or assurances of any kind as to the accuracy, currency or completeness of information. Access to and use of the content is at your own risk, and neither Greenbackers. nor any party involved in creating, producing, or delivering this site shall be liable for any damage of any kind arising out of, or resulting from, your access to, use of or inability to access or use this website, any omissions or errors in its content, or from your reliance on any information provided at this website.

© Copyright Greenbackers.com Inc 2014
All Rights Reserved
Greenbackers.com is a service mark of Greenbackers

 
 
 

No comments:

Post a Comment